ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1247

Adult-Onset Still’s Disease and Spondyloarthritis: Overlapping Syndrome or Incidental Association? A Series of 5 Cases

Aly Kamissoko 1, Nolan Hassold 2, Alexis Mathian 3, Edouard Pertuiset 4, Gaetane Nocturne 2, Bruno Fautrel 5 and Stéphane Mitrovic6, 1AP-HP, Department of Rheumatology, Pitié-Salpêtrière University Hospital, Paris, France, Paris, France, 2Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France., Paris, France, 3AP-HP, Service de Médecine Interne 2, Hôpital Universitaire Pitié-Salpêtrière, Paris, France, Paris, France, 4Rheumatology Department, Pontoise Hospital, Pontoise, France, Pontoise, France, 5Pitié-Salpêtrière Hospital, Department of Rheumatology, AP-HP, Sorbonne University, UPMC university, Paris, Ile-de-France, France, 6AP-HP, Department of Rheumatology, Pitié-Salpêtrière University Hospital, Sorbonne Université, GRC 08, Pierre Louis Institute of Epidemiology and Public Health, Paris, France - Centre d’Etude et de Référence sur les Maladies AutoInflammatoires et les Amyloses (CEREMAIA), FAI2R network, Paris, France - Institut Mutualiste Montsouris, Paris, France, Paris, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: psoriatic arthritis and SAPHO syndrome, Spondylarthritis, Spondylarthropathy, Still's disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Miscellaneous Rheumatic & Inflammatory Disease Poster II: Autoinflammation Related Diseases & Therapies

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Some forms of spondyloarthritis (SpA) such as SAPHO syndrome are classified as auto-inflammatory disorders. Association with adult onset Still’s disease (AoSD) has never been reported. We reported a case-series of 5 patients who presented features of both diseases.

Methods: Out of our cohort of 57 AoSD patients followed in our reference center, we identified 4 cases combining diagnosis of AOSD, on the basis of Yamaguchi’s and/or Fautrel’s classification criteria fulfilment, and SpA according to at least one classification criteria fulfilment: ASAS criteria for axial or peripheral spondylarthritis, Amor’s criteria for spondyloarthritis or CASPAR criteria for Psoriatic Arthritis (PsA). A fifth patient, followed in another university center and combining both diseases according to the same criteria, was subsequently included. Medical past history, family background, AOSD and SpA onset and evolution, clinical, biological and radiological features, and treatment response were extracted retrospectively from medical chart through a pre-defined form.

Results: The 5 patients (3M, 2W) displayed the following characteristics (Table): mean age 43.4 ± 15.4 years, mean age at AoSD and SpA onset 35.4 ± 13.3 and 37.4 ± 12.5 years respectively, mean follow-up duration 8.0 ± 6.2 years (range 1-18 years). Four patients were Caucasian, one African, with no consanguinity. SpA manifestations occurred after AoSD onset in 4 patients (mean delay 5.2 ± 4.7 years); AoSD was diagnosed 11 years after SpA diagnosis in the 5th patient. At AoSD onset, the 4 cardinal symptoms were present: mean fever 39.2 ± 0.8°C, arthralgia and arthritis and skin rash in all patients, mean white blood count was 16,091 ± 4302/mm3 (89.2% of polymorphonuclears), mean ESR 74 ± 33 mm, mean CRP 156.5 ± 74.5 mg/L, mean ferritin was 658.6 ± 340.9 µg/L.

SpA-related symptoms are indicated in the Table. Two patients fulfilled the criteria for axial spondyloarthritis, two for peripheral spondyloarthritis, three for PsA and one for SAPHO syndrome. Three patients had personal and one had familial medical history of skin psoriasis. HLA B27 was negative in 4 patients (status unavailable in one patient). Besides the classical AOSD carpal ankylosis and narrowing of proximal and distal interphalangeal (PIP, PID) joints found in 3 patients, radiological features of SpA were observed: bilateral calcaneal enthesophytes; uni- or bilateral sacroiliitis suggestive of spondyloarthritis (Figure 1); erosion, ankylosis and reconstruction “PsA-like” signs on PIP and DIP (Figure 2); multifocal osteitis and osteolytic bone lesion suggestive of SAPHO. Articular symptoms responded well to biotherapies prescribed for AOSD (anakinra, tocilizumab or TNF inhibitors) in 4 patients; in the 5th patient, prednisone and methotrexate were sufficient to control symptoms.

Conclusion: The prevalence of SpA in our AOSD cohort was around 7.0%, thus greater than the prevalence of 0.3% in the French general population (Saraux et al. Ann Rheum Dis. 2005 Oct;64(10):1431-5). The association of both diseases suggests a possible pathophysiological link between these 2 entities.


Table abstractV4

Table: patients’ characteristics. –*The patient presented 2 out of the 3 criteria needed -arthritis + enthesitis-. AOSD, Adult-Onset Still’s Disease – DIP, distal interphalangeal joint – MRI, magnetic resonance imaging –MTP, metatarsophalangeal joint – PIP, proximal interphalangeal joint – SpA, spondylarthropathy

Figure 1. Inflammatory sacroiliitis suggestive of spondylarthritis on MRI

Figure 2. Besides the classical bilateral carpal ankylosis, please note erosion, ankylosis and reconstruction “Psoriatic Arthritis-like” signs on proximal and distal interphalangeal joints


Disclosure: A. Kamissoko, None; N. Hassold, None; A. Mathian, None; E. Pertuiset, None; G. Nocturne, None; B. Fautrel, AbbVie, 2, 5, 8, Biogen, 5, 8, BMS, 5, 8, Boehringer Ingelheim, 8, Celgene, 5, 8, Eli Lilly and Company, 2, 5, Janssen, 5, 8, Lilly, 8, Medac, 5, 8, MSD, 2, 5, 8, NORDIC Pharma, 5, 8, Novartis, 5, 8, Pfizer, 2, 5, 8, Roche, 5, 8, Sanofi-Aventis, 5, SOBI, 5, 8, UCB, 5, 8; S. Mitrovic, None.

To cite this abstract in AMA style:

Kamissoko A, Hassold N, Mathian A, Pertuiset E, Nocturne G, Fautrel B, Mitrovic S. Adult-Onset Still’s Disease and Spondyloarthritis: Overlapping Syndrome or Incidental Association? A Series of 5 Cases [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/adult-onset-stills-disease-and-spondyloarthritis-overlapping-syndrome-or-incidental-association-a-series-of-5-cases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adult-onset-stills-disease-and-spondyloarthritis-overlapping-syndrome-or-incidental-association-a-series-of-5-cases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology